Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.20B |
| Enterprise value | 3.36B |
| Trailing P/E | N/A |
| Forward P/E | 72.99 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.01 |
| Price/book (mrq) | 19.99 |
| Enterprise value/revenue | 8.42 |
| Enterprise value/EBITDA | -36.50 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.76 |
| 52-week change 3 | -6.32% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 14.57 |
| 52-week low 3 | 9.70 |
| 50-day moving average 3 | 12.15 |
| 200-day moving average 3 | 12.25 |
Share statistics
| Avg vol (3-month) 3 | 3.01M |
| Avg vol (10-day) 3 | 2.59M |
| Shares outstanding 5 | 295.38M |
| Implied shares outstanding 6 | 295.38M |
| Float 8 | 222.12M |
| % held by insiders 1 | 0.75% |
| % held by institutions 1 | 109.92% |
| Shares short (28 Mar 2024) 4 | 32.49M |
| Short ratio (28 Mar 2024) 4 | 9.84 |
| Short % of float (28 Mar 2024) 4 | 11.05% |
| Short % of shares outstanding (28 Mar 2024) 4 | 11.00% |
| Shares short (prior month 29 Feb 2024) 4 | 30.91M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -37.96% |
| Operating margin (ttm) | -3.21% |
Management effectiveness
| Return on assets (ttm) | -6.12% |
| Return on equity (ttm) | -107.04% |
Income statement
| Revenue (ttm) | 399.36M |
| Revenue per share (ttm) | 1.35 |
| Quarterly revenue growth (yoy) | 30.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -65.62M |
| Net income avi to common (ttm) | -151.58M |
| Diluted EPS (ttm) | -0.51 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 286.2M |
| Total cash per share (mrq) | 0.97 |
| Total debt (mrq) | 445.06M |
| Total debt/equity (mrq) | 277.86% |
| Current ratio (mrq) | 2.88 |
| Book value per share (mrq) | 0.55 |
Cash flow statement
| Operating cash flow (ttm) | -69.09M |
| Levered free cash flow (ttm) | -25.89M |
© 2024 Yahoo. All rights reserved.